RecruitingNCT05556395
Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline
Sponsor
Johns Hopkins University
Enrollment
150 participants
Start Date
Apr 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this study is to gain a better understanding of why some individuals who have suffered a stroke experience post-stroke cognitive decline. Specifically this study is testing whether global disruption of the blood-brain barrier detected at the time of the stroke is informative about the risk of post-stroke cognitive decline over the next 3 years.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Acute ischemic stroke demonstrated on an MRI scan that includes perfusion imaging with an exogenous contrast agent
Exclusion Criteria1
- Inability to perform telephone-based cognitive assessments
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05556395
Related Trials
Imaging the Pathogenesis of Cerebral Small Vessel Disease
NCT057033861 location
Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy
NCT0597668525 locations
Augmented Renal Clearance in Neurocritical Care
NCT074106243 locations
The Southern-Norway Post-Stroke Atrial Fibrillation Study
NCT074077901 location
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation
NCT0713930140 locations